Pubblicazioni

P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study

2024 - JACC: CARDIOVASCULAR INTERVENTIONS
Ortega-Paz, Luis; Bor, Wilbert; Franchi, Francesco; van de Broek, Wout W. A.; Rollini, Fabiana; Giordano, Salvatore; Galli, Mattia; Been, Latonya; Ghanem, Ghussan; Shalhoub, Awss; Garabedian, Haroutioun; Al Saleh, Tala; Uzunoglu, Ekin; Zhou, Xuan; Rivas, Andrea; Pineda, Andres M.; Suryadevara, Siva; Soffer, Daniel; Mahowald, Madeline K.; Choi, Calvin Y.; Zenni, Martin M.; Phoenix, Fladia; Ajjan, Ramzi A.; ten Berg, Jurrien M.; Angiolillo, Dominick J.

Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications

2023 - EXPERT REVIEW OF CLINICAL PHARMACOLOGY
Galli, Mattia; Franchi, Francesco; Rollini, Fabiana; Ortega-Paz, Luis; D'Amario, Domenico; De Caterina, Raffaele; Mehran, Roxana; Michael Gibson, C; Angiolillo, Dominick J.

Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin. A pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy

2022 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia; Franchi, Francesco; Rollini, Fabiana; Been, Latonya; Abou Jaoude, Patrick; Rivas, Andrea; Zhou, Xuan; Jia, Sida; Maaliki, Naji; Hoon Lee, Chang; M Pineda, Andres; Suryadevara, Siva; Soffer, Daniel; M Zenni, Martin; Geisler, Tobias; K Jennings, Lisa; A Bass, Theodore; J Angiolillo, Dominick

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma